Transperineal Prostate Biopsy Is the New Black: What Are the Next Targets?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35216857.
- Also identified by DOI 10.1016/j.eururo.2022.01.046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transperineal biopsy is recommended as the first-choice technique for diagnosis of prostate cancer owing to lower rates of postprocedural sepsis. However, unresolved issues such as biopsy quality, lack of a systematic biopsy template, cost-effectiveness, and the risk of acute urine retention are yet to be resolved by the urological community.
Medical subject headings
- Prostatic Neoplasms
- Urinary Retention